Contact Congress about S. 2294: Kay Hagan Tick Reauthorization Act

Federal tick and bug-borne disease programs would keep running through 2030. States, local health departments, and regional centers would still get support, but the bill sets slightly lower funding limits than before.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Kay Hagan Tick Reauthorization Act is a Senate bill in committee. The latest recorded action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S4370-4371).

Latest action on S. 2294: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S4370-4371)

Who this affects: This bill mainly affects state and local health departments, regional disease centers, researchers, public health workers, and people affected by tick-borne or other bug-borne diseases. Health departments could keep getting federal help to track and respond to these diseases. Regional centers could keep supporting research and training. Patients and families could be affected by how well these programs improve tracking, prevention, and response, though the bill does not promise a specific health result.

Why this matters: Tick-borne and other bug-borne diseases can be hard to track, prevent, and treat. This bill keeps federal support in place for that work. State and local health departments often need help to watch for outbreaks and respond. The bill may help keep research, training, and public health planning steady, but it does not say whether disease rates or health outcomes would improve.

Key provisions in S. 2294

• The national plan for bug-borne diseases would stay in place after 2025. So would the regional Centers of Excellence in Vector-Borne Disease.
• HHS would no longer have to consult one named Tick-Borne Disease Working Group. It could instead work with “appropriate individuals,” which gives the agency more choice.
• The bill allows up to $8 million a year for the national plan and regional centers from 2026 through 2030. The old limit was $10 million a year for 2021 through 2025.
• The bill allows up to $19 million a year in extra help for health departments from 2026 through 2030. The old limit was $20 million a year for 2021 through 2025.
• The bill updates two parts of the Public Health Service Act, the main federal public health law. Those updates extend the funding authority for these programs.

How Modern Action helps you take action on S. 2294

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about S. 2294

What is S. 2294?

Federal tick and bug-borne disease programs would keep running through 2030. States, local health departments, and regional centers would still get support, but the bill sets slightly lower funding limits than before.

How do I support or oppose S. 2294?

Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.

Who should I contact about S. 2294?

Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.

Can Modern Action explain S. 2294 before I act?

Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.